Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WPD Pharmaceuticals Inc WPDPF


Primary Symbol: C.WBIO

Industrials Technology
WPD Pharmaceuticals Inc. is a Canada-based clinical-stage pharmaceutical company, with a focus on glioblastoma cancer (GBM) and other brain tumor programs. The Company is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. It has four novel drug candidates with one in... see more

Bullboard (CSE:WBIO)

View:
1 2 3 Next
Post by Betteryear2on Mar 07, 2022 7:57am

Signs Consortium Agreement on EuroNanoMed Project

VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical ...more  
158
Post by Blockyon Jan 10, 2021 10:50am

WPD and Moleculin could...

WPD and Moleculin could be  worth over 300 million? Only because of one drug?  https://ir.moleculin.com/press-releases/detail/201/moleculin-announces-fda-approves-3-rare-pediatric-disease ...more  
346
Comment by Blockyon Jan 08, 2021 9:50am

RE:Ph.D. Waldemar Priebe = new Jeff Bezos

If the CEO of WPD is the new Jeff Bezos, then we will be rich very soon...
235
Discussion
Comment by Blockyon Jan 08, 2021 9:30am

RE:WPD Berubicin Drug Candidate trial to start

Good Guy! New Blockbuster in the market?
162
Discussion
Comment by Blockyon Jan 08, 2021 7:00am

RE:WPD Berubicin Drug Candidate trial to start

When will we get the first results? 
168
Discussion
Post by Blockyon Jan 08, 2021 6:52am

Ph.D. Waldemar Priebe = new Jeff Bezos

Waldemar Priebe is my new Jeff Bezos! Mr. Priebe is the founder of WPD Pharmaceuticals, the founder of Reta Pharmaceuticals (whose stock has risen from $11 to $260), the founder of CNS ...more  
327
Discussion
Post by Blockyon Jan 07, 2021 4:36pm

Berubicin + Covid19 drug: let´s get ready to rumble!

Not only Berubicin cound be worth more than 1 billion, but also WP1122 could heal Covid19 patients... let´s get ready to rumble!
154
Post by etceteraon Oct 26, 2020 8:10am

WPD Berubicin Drug Candidate trial to start

Last week, WPD met with Worldwide Clinical Trials, a world-renowned Contract Research Organization engaged to coordinate and supervise the start-up of WPD’s Phase 1 and 2 clinical trials on Berubicin. ...more  
238
Discussion
Post by etceteraon Oct 15, 2020 8:06am

New Chief Medical Officer to Lead Phase I and II Clinic Tria

Marek has over 20 years of experience in clinical research in oncology (haematology and solid tumours), neuropsychiatry, diabetes and cardiovascular fields. He brings international expert knowledge ...more  
141
Post by etceteraon Sep 17, 2020 8:20am

US FDA Grant Fast-Track Glioblastoma Treatments

Unfortunately, glioblastoma is an aggressive brain tumor that still remains difficult to treat. To this day, there is still an unmet need for treatment, with only 8.7% of patients surviving for up to ...more  
202
Post by etceteraon Sep 16, 2020 7:48am

Prepayment of $705,000

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101 VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals ...more  
138
Post by etceteraon Sep 09, 2020 7:51am

Worldwide Clinical Trials as CRO for Phase 2 Berubicin Trial

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (“WPD” or the “Company”) (CSE: WBIO) (FSE: 8SV1), a clinical stage pharmaceutical company, is pleased to ...more  
189
Post by etceteraon Sep 01, 2020 9:42am

WPD Demonstrating Highly Effective Anticancer Therapy

WPD Pharmaceuticals Announces New Publication Demonstrating Highly Effective Anticancer Therapy in Animals with Spontaneous Tumors using WPD101 Drug Candidate Combination of IL-13RA2- and EphA2 ...more  
156
Post by etceteraon Jul 28, 2020 7:54am

Killer of malignant tumors of the central nervous system

The breakthrough of WPD’s solution is that WPD101a binds specifically to IL-13α2 receptors overexpressed on GBM cells. Binding of WPD101a to IL-13Rα2 expressing tumor cells is followed by ...more  
169
Post by etceteraon Jul 23, 2020 7:53am

Testing Confirms Antiviral Activity

Second round of independent laboratory testing confirmed the antiviral activity of WP1122 against coronavirus WP1122 against coronavirus July 23, 2020 07:30 ET | Source: WPD ...more  
158
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities